LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer

ABSTRACT: RATIONALE: LMB-9 immunotoxin can locate tumor cells and kill them without harming normal cells. This may be an effective treatment for advanced pancreatic, esophageal, stomach, colon or rectal cancer. PURPOSE: Phase I trial to study the effectiveness of LMB-9 immunotoxin in treating patients who have advanced pancreatic, esophageal, stomach, colon, or rectal cancer.

DISEASE(S): Adenocarcinoma,Esophageal Neoplasms,Colorectal Cancer,Gastric Cancer,Esophageal Cancer,Pancreatic Cancer,Stomach Neoplasms,Pancreatic Neoplasms

PROVIDER: 2005775 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR